Mark Alan Goldberg Glycomimetics Inc (GLYC) insider trading activity

Mark Alan Goldberg is of GLYCOMIMETICS INC. Currently has a direct ownership of 24,828 shares of GLYC, which is worth approximately $8,193. The most recent transaction as insider was on Mar 29, 2024, when has been sold 4,584 shares (Common Stock) at a price of $3.0 per share, resulting in proceeds of $13,752. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.8K

22.64% 3M change

372.91% 12M change

Total Value Held $8,193

Mark Alan Goldberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 29 2024	BUY Grant, award, or other acquisition	$13,752 $3.0 p/Share	4,584 Added 15.59%	24,828 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$13,751 $2.36 p/Share	5,827 Added 22.35%	20,244 Common Stock
Sep 30 2023	BUY Grant, award, or other acquisition	$13,750 $1.5 p/Share	9,167 Added 38.87%	14,417 Common Stock
May 18 2021	BUY Grant, award, or other acquisition	-	5,250 Added 50.0%	5,250 Common Stock

Also insider at

IMGN

ImmunoGen, Inc. Healthcare

Director

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

BPMC

Blueprint Medicines Corp Healthcare

MAG